CD8A and neoplasm: Subsequent comparison of different routes of administration of MCMV vectors containing antigens of HPV16 has shown that IP and subcutaneous routes induce prominent TEM-like CD8 T cell responses and complete protection against tumour challenge, while intranasal (IN) infection results in weak responses and partial protection [36].